Thursday, 1 June 2017

The Development of Prophylactic EBV Vaccines

Prophylactic EBV Vaccines
Epstein-Barr virus (EBV) is an important global human pathogen found in over 90% of the world’s population. EBV infection usually occurs in young children and causes no or only nonspecific symptoms. However, EBV is the major cause of infectious mononucleosis.

Epstein-Barr virus (EBV) is an important global human pathogen found in over 90% of the world’s population. EBV infection usually occurs in young children and causes no or only nonspecific symptoms.

However, EBV is the major cause of infectious mononucleosis (IM). EBV is an oncogenic virus associated with various human malignancies of both epithelial and lymphoid origin such as nasopharyngeal carcinoma (NPC), a subset of gastric carcinoma (GC), Burkitt’s lymphoma (BL), Hodgkin lymphoma (HL) and post-transplant lymphoproliferative disorder.

No comments:

Post a Comment